A Preview Of GeneDx Hldgs's Earnings
GeneDx Holdings Corp. Class A WGS | 66.89 66.89 | +0.42% 0.00% Post |
GeneDx Hldgs (NASDAQ:WGS) will release its quarterly earnings report on Monday, 2026-02-23. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate GeneDx Hldgs to report an earnings per share (EPS) of $0.12.
The market awaits GeneDx Hldgs's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
During the last quarter, the company reported an EPS beat by $0.12, leading to a 4.15% drop in the share price on the subsequent day.
Here's a look at GeneDx Hldgs's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.37 | 0.1 | 0.09 | 0.1 |
| EPS Actual | 0.49 | 0.5 | 0.27 | 0.6 |
| Price Change % | -4.00 | 13.0 | -7.00 | -1.0 |
Stock Performance
Shares of GeneDx Hldgs were trading at $90.68 as of February 19. Over the last 52-week period, shares are down 8.06%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
Insights Shared by Analysts on GeneDx Hldgs
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on GeneDx Hldgs.
GeneDx Hldgs has received a total of ratings from analysts, with the consensus rating as . With an average one-year price target of $, the consensus suggests a potential .
To track all earnings releases for GeneDx Hldgs visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.